-
Signature
-
/s/ Nathan Salha, as Attorney-in-Fact for Sean P. Duffy
-
Issuer symbol
-
OMDA
-
Transactions as of
-
10 Dec 2025
-
Transactions value $
-
-$142,379
-
Form type
-
4
-
Filing time
-
12 Dec 2025, 16:14:15 UTC
Reporting Owners (1)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| Duffy Sean P. |
Chief Executive Officer, Director |
C/O OMADA HEALTH, INC., 611 GATEWAY BLVD, SUITE 120, SAN FRANCISCO |
/s/ Nathan Salha, as Attorney-in-Fact for Sean P. Duffy |
12 Dec 2025 |
0002069522 |
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
OMDA |
Common Stock |
Sale |
-$142K |
-9.27K |
-6.82% |
$15.37 |
127K |
10 Dec 2025 |
Direct |
F1, F2 |
| holding |
OMDA |
Common Stock |
|
|
|
|
|
861K |
10 Dec 2025 |
See footnote |
F3 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: